Clinical Trials Logo
  1. Home
  2. Papillary Thyroid Cancer
  3. NCT05873283
  4. Details
NCT05873283 Clinical Trial

Papillary Thyroid Cancer and Central Lymp Node Dissection

Papillary Thyroid Cancer Clinical Trial

Official title:
Is Central Lymph Node Dissection Necessary in Suspected Papillary Thyroid Cancer and Papillary Thyroid Cancer?

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05873283
Other study ID # 20210310
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 12, 2020
Est. completion date March 24, 2023

Study information
Verified date May 2023
Source Basaksehir Cam & Sakura Sehir Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.

Recruitment information / eligibility
Status Completed
Enrollment 250
Est. completion date March 24, 2023
Est. primary completion date February 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - B5 and B6 biopsy results Exclusion Criteria: - lobectomy

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey BasaksehirCamSakuraSehirH Istanbul

Sponsors (1)
Lead Sponsor Collaborator
Basaksehir Cam & Sakura Sehir Hospital

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Reaching 100 patients was the first target 100 patients 18 months
See also
  Status Clinical Trial Phase
Completed NCT01441154 - Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Active, not recruiting NCT04544111 - PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Phase 2
Recruiting NCT03469011 - A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. Phase 1
Recruiting NCT05752669 - Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
Recruiting NCT04076514 - The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma
Completed NCT06439745 - More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated
Active, not recruiting NCT01723202 - Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer Phase 2
Recruiting NCT05500508 - Oral AMXT 1501 Dicaprate in Combination With IV DFMO Phase 1/Phase 2
Active, not recruiting NCT02568267 - Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Phase 2
Unknown status NCT02140476 - Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy N/A
Recruiting NCT06286631 - Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
Completed NCT06325787 - Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma N/A
Terminated NCT01974284 - Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma N/A
Active, not recruiting NCT00984191 - Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid N/A
Active, not recruiting NCT04731467 - A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05668962 - Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC Phase 2
Completed NCT02178345 - Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Not yet recruiting NCT06133374 - Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
Completed NCT03470259 - Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging Phase 1
Active, not recruiting NCT04129411 - Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation N/A